Lactams
eMolecules 28562-53-0 | 4-Acetoxy-2-azetidinone | Ambeed | MFCD00010593 | 129.115 | C5H7NO3 | 97.000 | CC(=O)OC1CC(=O)N1 | 100g | 600833386
4-Acetoxy-2-azetidinone | Ambeed | 28562-53-0 | MFCD00010593 | 129.115 | C5H7NO3 | 97.000 | CC(=O)OC1CC(=O)N1 | 100g | 600833386
Medchemexpress LLC Tetrazine-tagged thalidomide | 2087490-42-2 | 98.6% | 571.58 g/mol | C29H29N7O6 | 100 MG
Tz-Thalidomide is a tetrazine-tagged derivative of thalidomide used in bioorthogonal click-chemistry and as an E3 ligase ligand for biochemical research. It contains a reactive tetrazine group for rapid conjugation via inverse electron demand Diels-Alder reactions and has been characterized for binding to BRD4.
- Tetrazine moiety enables rapid inverse electron demand Diels-Alder (iEDDA) click reactions.
- Functions as an E3 ligase ligand for targeted protein interaction studies.
- Documented binding affinity to BRD4 in biochemical assays.
- High purity suitable for research applications.
- Available as a solid and as a 10 mM solution in DMSO for experimental flexibility.
eMolecules D-acid-PEG4-Thalidomide-5-(PEG4-acid) | Broadpharm |770.782 | C35H50N2O17 | 98.000 | OC(=O)CCOCCOCCOCCOCCOc1cccc2C(=O)N(C3CCC(=O)N(CCOCCOCCOCCOCCC(O)=O)C3=O)C(=O)c12 | 100mg | 779524498
D-acid-PEG4-Thalidomide-5-(PEG4-acid) | Broadpharm |770.782 | C35H50N2O17 | 98.000 | OC(=O)CCOCCOCCOCCOCCOc1cccc2C(=O)N(C3CCC(=O)N(CCOCCOCCOCCOCCC(O)=O)C3=O)C(=O)c12 | 100mg | 779524498
eMolecules 1950635-17-2 | Thalidomide-5-(C6-amine) | Broadpharm400.435 | C20H24N4O5 | 98.000 | NCCCCCCNC(=O)c1ccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c2c1 | 100mg | 713699636
Thalidomide-5-(C6-amine) | Broadpharm | 1950635-17-2400.435 | C20H24N4O5 | 98.000 | NCCCCCCNC(=O)c1ccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c2c1 | 100mg | 713699636
eMolecules Thalidomide-5-(PEG4-amine) | Broadpharm |520.539 | C24H32N4O9 | 0.000 | NCCOCCOCCOCCOCCNC(=O)c1ccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c2c1 | 100mg | 713699642
Thalidomide-5-(PEG4-amine) | Broadpharm |520.539 | C24H32N4O9 | 0.000 | NCCOCCOCCOCCOCCNC(=O)c1ccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c2c1 | 100mg | 713699642
eMolecules Thalidomide-5-(PEG4-acid) | Broadpharm |549.533 | C25H31N3O11 | 98.000 | OC(=O)CCOCCOCCOCCOCCNC(=O)c1ccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c2c1 | 100mg | 713699648
Thalidomide-5-(PEG4-acid) | Broadpharm |549.533 | C25H31N3O11 | 98.000 | OC(=O)CCOCCOCCOCCOCCNC(=O)c1ccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c2c1 | 100mg | 713699648
Medchemexpress LLC Thalidomide | 50-35-1 | MFCD00153873 | 100.0% | C13H10N2O4 | 10MG
Thalidomide (analytical standard) is a high-purity reference compound (CAS 50-35-1) intended for research and analytical applications. It serves as a cereblon inhibitor standard for assay calibration, method development, and reference testing. Consult the certificate of analysis and safety data sheet for batch-specific purity and handling instructions.
- High purity (99.96%) suitable for analytical standards.
- Provided in small, laboratory-scale quantities for method development.
- Supplied with certificate of analysis and safety data sheet.
- Intended for research and analytical use only.
- Suitable for assays targeting cereblon-related activity.
Medchemexpress LLC Thalidomide-5-peg2-cl | 2230956-57-5 | 96.6% | C17H17ClN2O6 | 10MG
Thalidomide-5-PEG2-Cl is a thalidomide-derived cereblon (CRBN) ligand featuring a short PEG2 spacer and a terminal chloride. It is supplied as a research-grade building block for conjugation in PROTAC design and other CRBN-targeting chemical biology applications, with documented molecular formula and purity.
- Provides a CRBN-recruiting moiety suitable for PROTAC assembly.
- Contains a PEG2 linker for flexible conjugation to ligands.
- Terminal chloride enables straightforward chemical derivatization.
- Supplied with referenced purity and characterization data.
- Available in small research-friendly pack sizes for early-stage work.
Medchemexpress LLC Fc epsilon RIA/FCER1 50ug
Recombinant human Fc epsilon RI alpha (extracellular domain) supplied as 50 μg lyophilized material with an N-terminal His-SUMO tag, intended for binding and functional studies involving human IgE.
- Prepared as lyophilized powder for long-term storage and transport.
- Includes N-terminal His-SUMO tag to facilitate affinity purification.
- Expression system: E. coli for efficient production.
- High purity (>95%) as determined by reducing SDS-PAGE.
- Approximate molecular weight ~37 kDa for molecular characterization.
- Demonstrated IgE binding in ELISA with reported ED50 of 5.864 μg/mL.